Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,091,961
+$5,476,179 QoQ
Shares Held
83,818
+16.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.58%
of 13F equity value
Holder Rank
#588
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Engines Advisors L.L.C. holds $32,908,375 across 9 Drug Manufacturers - General names. ABBV ranks #1 (64.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
83,818 | $21,091,961 | |
| 2 | LLY |
ELI LILLY & Co
|
2,700 | $3,238,461 | |
| 3 | JNJ |
Johnson & Johnson
|
12,305 | $3,125,100 | |
| 4 | AMGN |
Amgen Inc
|
5,295 | $1,917,425 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,510 | $1,093,535 | |
| 6 | NVS |
Novartis AG
|
6,697 | $1,049,553 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,130 | $526,070 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,619 | $457,224 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,091,961 | 83,818 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,615,782 | 71,800 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,050,353 | 83,375 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $19,087,926 | 82,439 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $16,064,482 | 86,545 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,186,925 | 82,030 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $13,838,387 | 77,875 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $15,422,003 | 78,094 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,826,227 | 80,610 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,887,856 | 76,265 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $13,171,520 | 84,994 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,585,284 | 84,431 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,277,540 | 91,127 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $15,282,626 | 95,894 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,908,241 | 98,436 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,575,880 | 86,252 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $15,306,657 | 99,939 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $17,106,819 | 105,526 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $14,938,546 | 110,329 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $11,226,893 | 104,078 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,493,015 | 110,911 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $13,778,029 | 127,315 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $14,012,648 | 130,776 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $9,785,467 | 111,719 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $11,842,864 | 120,624 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,234,069 | 134,323 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||